In summary, our pan-cancer analysis of CDK1 showed a significant correlation between CDK1 expression and clinical prognosis, DNA methylation, protein phosphorylation, immune cell infiltration, RNA methylation regulatory proteins, tumor mutational load, and microsatellite instability in multiple tumors. The gene discussed is CDK1; the disease is cancer.